Departments of Family Medicine.
Nutritional Sciences.
J Nutr. 2019 Jul 1;149(7):1170-1179. doi: 10.1093/jn/nxy255.
The intestinal microbiome is an important determinant of inflammatory balance in the colon that may affect response to dietary agents.
This is a secondary analysis of a clinical trial, the Fish Oil Study, to determine whether interindividual differences in colonic bacteria are associated with variability in the reduction of colonic prostaglandin E2 (PGE2) concentrations after personalized supplementation with ω-3 (n-3) fatty acids.
Forty-seven healthy adults (17 men, 30 women, ages 26-75 y) provided biopsy samples of colonic mucosa and luminal stool brushings before and after personalized ω-3 fatty acid supplementation that was based on blood fatty acid responses. Samples were analyzed using 16S ribosomal RNA sequencing. The data analyses focused on changes in bacterial community diversity. Linear regression was used to evaluate factors that predict a reduction in colonic PGE2.
At baseline, increased bacterial diversity, as measured by the Shannon and Inverse Simpson indexes in both biopsy and luminal brushing samples, was positively correlated with dietary fiber intakes and negatively correlated with fat intakes. Dietary supplementation with ω-3 fatty acids increased the Yue and Clayton community dis-similarity index between the microbiome in luminal brushings and colon biopsy samples post-supplementation (P = 0.015). In addition, there was a small group of individuals with relatively high Prevotella abundance who were resistant to the anti-inflammatory effects of ω-3 fatty acid supplementation. In linear regression analyses, increases in diversity of the bacteria in the luminal brushing samples, but not in the biopsy samples, were significant predictors of lower colonic PGE2 concentrations post-supplementation in models that included baseline PGE2, baseline body mass index, and changes in colonic eicosapentaenoic acid-to-arachidonic acid ratios. The changes in bacterial diversity contributed to 6-8% of the interindividual variance in change in colonic PGE2 (P = 0.001).
Dietary supplementation with ω-3 fatty acids had little effect on intestinal bacteria in healthy humans; however, an increase in diversity in the luminal brushings significantly predicted reductions in colonic PGE2. This trial was registered at www.clinicaltrials.gov as NCT01860352.
肠道微生物群是影响结肠炎症平衡的重要决定因素,它可能影响对饮食因素的反应。
这是一项鱼油研究的临床试验的二次分析,旨在确定个体间结肠细菌的差异是否与个性化补充 ω-3(n-3)脂肪酸后结肠前列腺素 E2(PGE2)浓度降低的变异性相关。
47 名健康成年人(17 名男性,30 名女性,年龄 26-75 岁)在个性化 ω-3 脂肪酸补充前后提供结肠黏膜活检样本和腔刷粪便样本,该补充基于血液脂肪酸反应。使用 16S 核糖体 RNA 测序分析样本。数据分析集中于细菌群落多样性的变化。线性回归用于评估预测结肠 PGE2 降低的因素。
在基线时,活检和腔刷样本中细菌多样性的增加(用 Shannon 和 Inverse Simpson 指数衡量)与膳食纤维摄入量呈正相关,与脂肪摄入量呈负相关。ω-3 脂肪酸的饮食补充增加了补充后腔刷和结肠活检样本中微生物组之间的 Yue 和 Clayton 群落不相似性指数(P = 0.015)。此外,还有一小部分个体的普雷沃氏菌丰度相对较高,对 ω-3 脂肪酸补充的抗炎作用有抗性。在线性回归分析中,腔刷样本中细菌多样性的增加,但活检样本中没有,是补充后结肠 PGE2 浓度降低的显著预测因素,这些模型包括基线 PGE2、基线体重指数和结肠二十碳五烯酸-花生四烯酸比值的变化。细菌多样性的变化对结肠 PGE2 变化的个体间差异的贡献为 6-8%(P = 0.001)。
ω-3 脂肪酸的饮食补充对健康人肠道细菌的影响很小;然而,腔刷中多样性的增加显著预测了结肠 PGE2 的降低。该试验在 www.clinicaltrials.gov 上注册为 NCT01860352。